Related references
Note: Only part of the references are listed.Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - A review
Markku Miettinen et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Expression of the Receptor for Type I Insulin-like Growth Factor (IGF1R) in Gastrointestinal Stromal Tumors An Immunohistochemical Study of 1078 Cases With Diagnostic and Therapeutic Implications
Jerzy Lasota et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Immunohistochemical Loss of Succinate Dehydrogenase Subunit A (SDHA) in Gastrointestinal Stromal Tumors (GISTs) Signals SDHA Germline Mutation
Markku Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Gastrointestinal stromal tumors in children and young adults: a clinicopathologic and molecular genetic study of 22 Korean cases
Guhyun Kang et al.
APMIS (2013)
The role of complex II in disease
Attje S. Hoekstra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2013)
Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors
Ricardo Celestino et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2013)
Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction
Margherita Nannini et al.
FUTURE ONCOLOGY (2013)
Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors
Andrew J. Wagner et al.
MODERN PATHOLOGY (2013)
Gastrointestinal stromal tumour
Heikki Joensuu et al.
LANCET (2013)
Post-Transcriptional Dysregulation by miRNAs Is Implicated in the Pathogenesis of Gastrointestinal Stromal Tumor [GIST]
Lorna Kelly et al.
PLOS ONE (2013)
Clinical Significance of Insulin-Growth Factor 1 and Insulin-Growth Factor 1 Receptor Expression in Gastrointestinal Stromal Tumors
Mi-Jin Gu et al.
HEPATO-GASTROENTEROLOGY (2013)
Succinate Dehydrogenase-deficient Tumors: Diagnostic Advances and Clinical Implications
Justine A. Barletta et al.
ADVANCES IN ANATOMIC PATHOLOGY (2012)
'Big'-Insulin-Like Growth Factor-II Signaling Is an Autocrine Survival Pathway in Gastrointestinal Stromal Tumors
Bart Rikhof et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Loss of succinate dehydrogenase subunit B (SDHB) expression is limited to a distinctive subset of gastric wild-type gastrointestinal stromal tumours: a comprehensive genotype-phenotype correlation study
Leona A. Doyle et al.
HISTOPATHOLOGY (2012)
Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression
Angela Chou et al.
MODERN PATHOLOGY (2012)
Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts
Heikki Joensuu et al.
LANCET ONCOLOGY (2012)
Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia
Anthony J. Gill
PATHOLOGY (2012)
KIT Mutations and Sequence Changes in Genes Encoding SDH Complex Possibly Need Not be Mutually Exclusive in Gastrointestinal Stromal Tumors
Daum Ondrej et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Michael Pollak
NATURE REVIEWS CANCER (2012)
A Distinct Pediatric-type Gastrointestinal Stromal Tumor in Adults: Potential Role of Succinate Dehydrogenase Subunit A Mutations
Maria A. Pantaleo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Pediatric-type Gastrointestinal Stromal Tumors in Adults: Distinctive Histology Predicts Genotype and Clinical Behavior
Tanya A. Rege et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Succinate Dehydrogenase-Deficient GISTs: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 66 Gastric GISTs With Predilection to Young Age
Markku Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Pediatric-Type Gastrointestinal Stromal Tumors Are SDHB Negative (Type 2) GISTs
Anthony J. Gill et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Serial analysis of resected prostate cancer suggests up-regulation of type 1 IGF receptor with disease progression
Benjamin W. Turney et al.
BJU INTERNATIONAL (2011)
Minireview: IGF, Insulin, and Cancer
Emily J. Gallagher et al.
ENDOCRINOLOGY (2011)
Systemic Therapy for Advanced Gastrointestinal Stromal Tumors: Beyond Imatinib
Edward J. Kim et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
SDHA Loss-of-Function Mutations in KIT-PDGFRA Wild-Type Gastrointestinal Stromal Tumors Identified by Massively Parallel Sequencing
Maria A. Pantaleo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors
Jose Gaal et al.
MODERN PATHOLOGY (2011)
Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo
C. Algire et al.
ONCOGENE (2011)
Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations
Katherine A. Janeway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Gastrointestinal stromal tumours: origin and molecular oncology
Christopher L. Corless et al.
NATURE REVIEWS CANCER (2011)
Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types
Anthony J. Gill et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Gastric Stromal Tumors in Carney Triad Are Different Clinically, Pathologically, and Behaviorally From Sporadic Gastric Gastrointestinal Stromal Tumors: Findings in 104 Cases
Lizhi Zhang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase
Carolyn Algire et al.
ENDOCRINE-RELATED CANCER (2010)
SDHA is a tumor suppressor gene causing paraganglioma
Nelly Burnichon et al.
HUMAN MOLECULAR GENETICS (2010)
Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without IGF1R genomic amplification
Katherine A. Janeway et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Mutations of the Metabolic Genes IDH1, IDH2, and SDHAF2 Are Not Major Determinants of the Pseudohypoxic Phenotype of Sporadic Pheochromocytomas and Paragangliomas
Li Yao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Succinate dehydrogenase - Assembly, regulation and role in human disease
Jared Rutter et al.
MITOCHONDRION (2010)
Targeting Insulin-Like Growth Factor Signaling: Rational Combination Strategies
David Olmos et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Research Resource: Transcriptional Profiling Reveals Different Pseudohypoxic Signatures in SDHB and VHL-Related Pheochromocytomas
Elena Lopez-Jimenez et al.
MOLECULAR ENDOCRINOLOGY (2010)
Gastrointestinal stromal tumors
Bernadette Liegl-Atzwanger et al.
VIRCHOWS ARCHIV (2010)
Insulin Receptor Isoform A and Insulin-like Growth Factor II as Additional Treatment Targets in Human Osteosarcoma
Sofia Avnet et al.
CANCER RESEARCH (2009)
Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure
S. George et al.
EUROPEAN JOURNAL OF CANCER (2009)
Insulin-like growth factor 1 receptor expression in wild-type GISTs: A potential novel therapeutic target
Maria A. Pantaleo et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications
C. A. Stratakis et al.
JOURNAL OF INTERNAL MEDICINE (2009)
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
Francien H. van Nederveen et al.
LANCET ONCOLOGY (2009)
Lymph node metastasis in gastrointestinal stromal tumours (GIST) occurs preferentially in young patients <= 40 years: an overview based on our case material and the literature
Abbas Agaimy et al.
LANGENBECKS ARCHIVES OF SURGERY (2009)
Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions
A. Gualberto et al.
ONCOGENE (2009)
Sunitinib Treatment in Pediatric Patients With Advanced GIST Following Failure of Imatinib
Katherine A. Janeway et al.
PEDIATRIC BLOOD & CANCER (2009)
Human cancers converge at the HIF-2α oncogenic axis
Aleksandra Franovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma
Huai-Xiang Hao et al.
SCIENCE (2009)
Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients
C. Braconi et al.
ANNALS OF ONCOLOGY (2008)
The Type 1 Insulin-Like Growth Factor Receptor Pathway
Meenali M. Chitnis et al.
CLINICAL CANCER RESEARCH (2008)
Molecular characterization of pediatric gastrointestinal stromal tumors
Narasimhan P. Agaram et al.
CLINICAL CANCER RESEARCH (2008)
Targeting insulin-like growth factor 1 receptor in sarcomas
Katia Scotlandi et al.
CURRENT OPINION IN ONCOLOGY (2008)
Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors
Narasimhan P. Agaram et al.
GENES CHROMOSOMES & CANCER (2008)
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors
Chi Tarn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer
William G. Kaelin
NATURE REVIEWS CANCER (2008)
KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway
S. Bauer et al.
ONCOGENE (2007)
Familial gastrointestinal stromal tumors and germ-line mutations
Sarah R. McWhinney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer
Aleksandra Franovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
HIF-2α promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity
John D. Gordan et al.
CANCER CELL (2007)
IGF2 is critical for tumorigenesis by synovial sarcoma oncoprotein SYT-SSX1
Y Sun et al.
ONCOGENE (2006)
Insulin-like growth factor receptor I targeting in epithelial ovarian cancer
WH Gotlieb et al.
GYNECOLOGIC ONCOLOGY (2006)
Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study
RK Yantiss et al.
MODERN PATHOLOGY (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
MA Selak et al.
CANCER CELL (2005)
Role of VHL gene mutation in human cancer
WY Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The insulin-like growth factor system and cancer
D LeRoith et al.
CANCER LETTERS (2003)
PDGFRA activating mutations in gastrointestinal stromal tumors
MC Heinrich et al.
SCIENCE (2003)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
IGF-I and GH post-receptor signaling mechanisms for pancreatic β-cell replication
CJ Rhodes
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2000)
Share Paper
